Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases

&
Ethics and International Affairs 19 (3) (2005)
  Copy   BIBTEX

Abstract

The authors suggest creating a scheme that offers new incentives for research on diseases disproportionately affecting the poor, with the goal of making development of neglected disease vaccines a lucrative endeavor for pharmaceutical companies

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,590

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases, Michael Kremer and Rachel Glennerster , 152 pp., $24.95 cloth. [REVIEW]Rekha Nath - 2005 - Ethics and International Affairs 19 (3):103-106.
Book Review: Michael Kremer and Rachel Glennerster, Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases. Princeton University Presss, Princeton, NJ and Oxford, UK. 2004. 153 pp. Hb, ISBN: 0-691-12113-3. [REVIEW]Amitrajeet A. Batabyal - 2005 - Journal of Agricultural and Environmental Ethics 18 (4):415-417.
Prizes and Parasites: Incentive Models for Addressing Chagas Disease.Sara E. Crager & Matt Price - 2009 - Journal of Law, Medicine and Ethics 37 (2):292-304.
Ethical issues in funding research and development of drugs for neglected tropical diseases.L. Oprea, A. Braunack-Mayer & C. A. Gericke - 2009 - Journal of Medical Ethics 35 (5):310-314.
Measuring Global Health Impact: Incentivizing Research and Development of Drugs for Neglected Diseases.Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Just Rules for Innovative Pharmaceuticals.Thomas Pogge - 2022 - Philosophies 7 (4):79.
Centring race, deprivation, and disease severity in healthcare priority setting.Arianne Shahvisi - 2022 - Journal of Medical Ethics 48 (2):77-78.
Bioethics and neglected diseases.Miguel Kottow - 2019 - New York: Nova Medicine & Health.
Epilogue: New Drugs for Neglected Diseases.Thomas Pogge & Aidan Hollis - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):329-334.
Human rights and global health: A research program.Thomas W. Pogge - 2005 - Metaphilosophy 36 (1‐2):182-209.

Analytics

Added to PP
2015-01-23

Downloads
2 (#1,450,151)

6 months
2 (#1,816,284)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

View all 9 citations / Add more citations

References found in this work

No references found.

Add more references